KALARIS THERAPEUTICS INC (KLRS) Stock Balance Sheet
NASDAQ:KLRS - Nasdaq - US4829291065 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 100.97M | 118.29M | 90.12M | 106.10M | 201.70M | |||
| Marketable Securities | N/A | 0.00 | 93.82M | 127.70M | 46.50M | |||
| Receivables | N/A | 0.00 | 206.00K | 200.00K | 100.00K | |||
| Other Current Assets | 1.22M | 257.00K | 3.49M | 9.10M | 5.20M | |||
| Total Current Assets | 102.18M | 118.55M | 187.63M | 243.10M | 253.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 2.19M | 32.60M | 31.30M | |||
| Other Non-Current Assets | 910.00K | N/A | 974.00K | 1.50M | 2.00M | |||
| Total Non-Current Assets | 910.00K | 0.00 | 3.16M | 34.00M | 33.30M | |||
| TOTAL ASSETS | 103.09M | 118.55M | 190.80M | 277.10M | 286.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.54M | 4.99M | 20.87M | 21.20M | 26.70M | |||
| Accounts Payable | 2.37M | 247.00K | 6.76M | 3.00M | 8.40M | |||
| Other Current Liabilities | 230.00K | N/A | 739.00K | 200.00K | 2.70M | |||
| Total Current Liabilities | 7.14M | 5.24M | 28.37M | 24.30M | 37.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 32.08M | N/A | 16.65M | 28.20M | 23.50M | |||
| Total Non-Current Liabilities | 32.08M | 0.00 | 16.65M | 28.30M | 23.40M | |||
| TOTAL LIABILITIES | 39.22M | 5.24M | 45.02M | 52.60M | 61.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -126.76M | -714.96M | -656.19M | -465.80M | -297.10M | |||
| Additional Paid In Capital | 190.63M | 828.40M | 802.02M | 690.80M | 522.50M | |||
| Common Shares | 2.00K | 0.00 | 11.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | -135.00K | -62.00K | -500.00K | -200.00K | |||
| Shares Outstanding | 18.70M | 5.04M | 114.15M | 93.27M | 63.57M | |||
| Tangible Book Value per Share | 3.42 | 22.48 | 1.28 | 2.41 | 3.54 | |||
| Total Shareholders' Equity | 63.87M | 113.31M | 145.78M | 224.50M | 225.30M | |||
| TOTAL LIABILITIES AND EQUITY | 103.09M | 118.55M | 190.80M | 277.10M | 286.60M | |||
| Statistics | ||||||||
| Current Ratio | 14.31 | 22.63 | 6.61 | 10.00 | 6.68 | |||
| Return On Assets (ROA) | -37.51% | -49.77% | -99.58% | -60.88% | -60.00% | |||
| Return On Equity (ROE) | -60.54% | -52.07% | -130.33% | -75.15% | -76.32% | |||
All data in USD , ROIC based on taxRate of 0.21